Stock Ticker

  • Loading stock data...

Investor’s Digest: Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX), Dynavax Technologies Corporation (NASDAQ:DVAX) and Avon Products, Inc.(NYSE:AVP)

Boston, MA 02/19/2014 (wallstreetpr) – Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX) has proposed to the town of Clifton that the road connecting Copper Verde with Shannon Hill be named as John Decker Drive. When the council meeting was in progress on Feb 13, at the Clifton Town limits, the name of the ex-Mayor who tragically passed away due to a heart attack on Thanksgiving Eve was proposed; it apparently received the required votes. It has been a tradition with McMoRan Copper & Gold Inc to name streets as well as roads that are part of its properties. Noticeably, much of it has been around the Clifton town limits. The current subdivision, which is Copper Verde is expected to see much expansion.

Dynavax Technologies Corporation (NASDAQ:DVAX) in a sudden turnaround has said it will not seek approval for Heplisav, from European regulators. However, this could be a temporary phase. The company has apparently withdrawn its application after the regulator raised doubts about the safety factor, given the fact that the current safety database is very small to rule out events of adversity. Since European regulation allows only a short-period of 180 days, which is distinctly insufficient for DVAX to collect additional data and complete the process. Therefore, Dynavax Technologies Corporation (NASDAQ:DVAX) may choose to rework its processes and return later to place an application again. In the next phase the clinical trial will include 8,000 patient clinical trial for Heplisav soon.

Avon Products, Inc. (NYSE:AVP) has just lost some edge, thanks to price cuts by analysts such as BMO Capital Markets. The share price for this company reportedly at $18 was revised to $15 by the analyst. However, the analyst did indicate that the upside for the self-grooming and lifestyle products company was about 3.09%, above the current prices. Though, Avon Products, Inc. (NYSE:AVP)’s earnings data did beat estimates by $0.04, the revenue the company earned was $2.70 as against the $2.75 estimated by analysts.

Published by Duncan Oleinic

Duncan Oleinic is from New Yourk. After graduating with a degree in physics, he began his career as an analyst in a broking firm. Through this experience he was able to advance to the role of correspondent for a U.S based financial news provider, where he worked from 2001 to 2007. He subsequently joined a merchant banking firm as a financial analyst focused on valuing unlisted companies in the sub-continent. Over the course of his two years here, he performed valuations of several media companies which were later acquired by peers.



  • Recent Stories

    SignUp Now For Our Featured Newsletter

    Sign Up To Get Our Latest Stocks Alerts